ClinicalTrials.Veeva

Menu

A Pilot Study to Evaluate the Effect of a Probiotic Mixture in Acne

B

Bionou Research

Status

Completed

Conditions

Acne
Acne Vulgaris

Treatments

Other: Placebo
Dietary Supplement: Probiotic Bths-003

Study type

Interventional

Funder types

NETWORK

Identifiers

NCT03878238
ACNE_PROB

Details and patient eligibility

About

A 12-week randomized, double-blind, placebo-controlled pilot study to evaluate the effect of a probiotic blend in the treatment and clinical and subjective evolution of acne vulgaris in adolescent and adult patients between 12 and 30 years.

Enrollment

25 patients

Sex

All

Ages

12 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Signature of informed consent by the patient (and their legal guardian in case of being under age).
  • Age between 12 and 30 years-old.
  • Moderate acne according to the AGSS (Acne Global Severity Scale) and / or GAGS (Global Acne Grading System) scales.

Exclusion criteria

  • Contraindication of any of the components of the product under study.
  • Topical or systemic use of antifungals and antibiotics in the previous 2 weeks.
  • Consumption of probiotics in the previous 2 months.
  • Use of systemic retinoids in the previous 6 months.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

25 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Treatment:
Other: Placebo
Probiotic
Experimental group
Treatment:
Dietary Supplement: Probiotic Bths-003

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems